What is the current stock price of The Oncology Institute, Inc. (TOI)?

As of the latest market data, The Oncology Institute, Inc. (TOI) is trading at $3.54. The stock has seen a loss of 0.00% today.

Does The Oncology Institute, Inc. (TOI) pay a dividend?

Based on current data, The Oncology Institute, Inc. does not have a confirmed active dividend policy.

What is the market cap of The Oncology Institute, Inc.?

The current market capitalization of The Oncology Institute, Inc. (TOI) is approximately unavailable.

TOI

The Oncology Institute, Inc.·Healthcare

3.54

0.000%(+0.00)

Market Closed

3.55

0.282%(+0.01)

After Hours

Last Updated: — ET

52W L: $2.0152W H: $4.88

TOI NEWS

globenewswire.com

3d ago

Topicus.com Inc. Announces Release Date for First Quarter Results

TORONTO, April 15, 2026 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its first quarter results on May 5, 2026.

defenseworld.net

3d ago

Jorey Chernett Purchases 20,000 Shares of Oncology Institute (NASDAQ:TOI) Stock

The Oncology Institute, Inc. (NASDAQ: TOI - Get Free Report) major shareholder Jorey Chernett acquired 20,000 shares of the firm's stock in a transaction on Thursday, April 9th. The shares were bought at an average price of $3.10 per share, for a total transaction of $62,000.00. Following the completion of the transaction, the insider owned 10,499,358

globenewswire.com

Apr 10

Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings

TORONTO, April 10, 2026 (GLOBE NEWSWIRE) -- The Topicus.com Inc. (“Topicus”) (TSXV:TOI) annual general meeting of shareholders will be held on Friday, May 15, 2026 at 8:00 a.m. ET using a hybrid meeting format with proceedings conducted via live webcast and in person. The Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) annual general meeting of shareholders will be held on Friday, May 15, 2026 at 8:15 a.m. ET using a hybrid meeting format with proceedings conducted via live webcast and in person. The Constellation Software Inc. (“Constellation” or “CSI”) (TSX:CSU) annual meeting of shareholders will be held on Friday, May 15, 2026 at 8:30 a.m. ET using a hybrid meeting format with proceedings conducted via live webcast and in person.

seekingalpha.com

Mar 13

The Oncology Institute, Inc. (TOI) Q4 2025 Earnings Call Transcript

globenewswire.com

Mar 12

The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026

CERRITOS, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2025.

globenewswire.com

Feb 13

Topicus.com Inc. Announces Release Date for Fourth Quarter Results

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its fourth quarter results on February 25, 2026.

Company Profile

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

Sector

Healthcare

Industry

Medical - Care Facilities

Employees

825

IPO Date

2020-06-04

Beta

0.20

Websitetheoncologyinstitute.com↗